Mathieu Peyrou
Impact in
- Equine top 10%
- Cell Biology top 10%
- Endoplasmic Reticulum Stress and Disease
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- Alastair E. Cribb (4 shared papers)Paul Hanna (2 shared papers)Shanmugam Muruganandan (1 shared paper)Jérôme M. Giraudel (8 shared papers)Jonathan P. Mochel (7 shared papers)Meindert Danhof (6 shared papers)Martin Fink (6 shared papers)Mark Deurinck (2 shared papers)
- Journals
- Journal of Veterinary Pharmacology and Therapeutics (6 papers)Toxicological Sciences (2 papers)Pharmaceutical Research (2 papers)Chronobiology International (2 papers)European Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- SwitzerlandFranceCanada
In The Last Decade
Mathieu Peyrou
21 papers receiving 561 citations
Peers
Comparison fields: 5 of 93
- Equine 15
- Cell Biology 138
- Pharmacology 133
- Pharmacology 62
- Small Animals 45
Countries citing papers authored by Mathieu Peyrou
This map shows the geographic impact of Mathieu Peyrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Peyrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Peyrou more than expected).
Fields of papers citing papers by Mathieu Peyrou
This network shows the impact of papers produced by Mathieu Peyrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Peyrou. The network helps show where Mathieu Peyrou may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Peyrou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 120 | |
| 2 | 2005 | 116 | |
| 3 | 2007 | 61 | |
| 4 | 2014 | 36 | |
| 5 | 2013 | 32 | |
| 6 | 2010 | 22 | |
| 7 | 2014 | 22 | |
| 8 | 2018 | 20 | |
| 9 | 2006 | 19 | |
| 10 | 2013 | 19 | |
| 11 | 2012 | 19 | |
| 12 | 2004 | 18 | |
| 13 | 2013 | 15 | |
| 14 | 2012 | 12 | |
| 15 | 2007 | 8 | |
| 16 | 2020 | 8 | |
| 17 | 2012 | 6 | |
| 18 | 2021 | 6 | |
| 19 | [Evolution of bacterial resistance to certain antibacterial agents in horses in a veterinary hospital]. | 2003 | 6 |
| 20 | 2014 | 3 |
About Mathieu Peyrou
Mathieu Peyrou is a scholar working on Pharmacology, Epidemiology, Cardiology and Cardiovascular Medicine, Clinical Biochemistry and Cell Biology, having authored 22 papers that have together received 570 indexed citations. Recurring topics across this work include Endoplasmic Reticulum Stress and Disease (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), Heart Failure Treatment and Management (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Renin-Angiotensin System Studies (3 papers), Hormonal Regulation and Hypertension (3 papers), Coccidia and coccidiosis research (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Equine (15 citations), Cell Biology (138 citations), Pharmacology (133 citations), Pharmacology (62 citations) and Small Animals (45 citations). Mathieu Peyrou has collaborated with scholars based in Switzerland, France and Canada. Frequent co-authors include Alastair E. Cribb, Paul Hanna, Shanmugam Muruganandan, Jérôme M. Giraudel, Jonathan P. Mochel, Meindert Danhof, Martin Fink, Mark Deurinck, Michèle Doucet and André Vrins. Their work appears in journals such as Journal of Veterinary Pharmacology and Therapeutics, Toxicological Sciences, Pharmaceutical Research, Chronobiology International and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.